Revolution Medicines, Inc. Annual Operating Lease, Payments in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Revolution Medicines, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2022.
  • Revolution Medicines, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $600K, a 14.3% decline year-over-year.
  • Revolution Medicines, Inc. Operating Lease, Payments for the twelve months ending March 31, 2023 was $2.3M.
  • Revolution Medicines, Inc. annual Operating Lease, Payments for 2022 was $2.4M, a 60% increase from 2021.
  • Revolution Medicines, Inc. annual Operating Lease, Payments for 2021 was $1.5M, a 42.3% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.4M +$900K +60% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-27
2021 $1.5M -$1.1M -42.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
2020 $2.6M Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.